Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study-Reference-Cited by-同舟云学术

Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study

Published:2013-01-14 Issue:3 Volume:42 Page:169-175
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Filippatos TD,Derdemezis CS,Voulgari PV,Tsimihodimos V,Elisaf MS,Tselepis AD,Drosos AA

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.3109/03009742.2012.745013

Reference48 articles.

1. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies

2. Rheumatoid Arthritis: Cardiovascular Manifestations, Pathogenesis, and Therapy

3. Carotid Intima Media Thickness in Rheumatoid Arthritis as Compared to Control Subjects: A Meta-Analysis

4. Early Treatment Reduces the Cardiovascular Risk Factors in Newly Diagnosed Rheumatoid Arthritis Patients

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nrf2-mediated ferroptosis inhibition: a novel approach for managing inflammatory diseases;Inflammopharmacology;2024-08-10

2. Elevated triglyceride levels are associated with increased risk for major adverse cardiovascular events in statin-naïve rheumatoid arthritis patients: A nationwide cohort study;Seminars in Arthritis and Rheumatism;2023-12

3. Dyslipidemia in rheumatoid arthritis: the possible mechanisms;Frontiers in Immunology;2023-10-25

4. N-Acetylcysteine overcomes epalrestat-mediated increase of toxic 4-hydroxy-2-nonenal and potentiates the anti-arthritic effect of epalrestat in AIA model;International Journal of Biological Sciences;2023

5. The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study;Heart and Vessels;2022-06-24